Kevin R Thornal
CIK 1783992 · Grp Pres-Global Business · last filed 2026-09-15
Kevin R Thornal is a Grp Pres-Global Business who has filed 29 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider sold $529.0K of ZBH on Sep 15, 2026. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. 4 SEC filings were submitted jointly with ZIMMER BIOMET HOLDINGS, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HOLX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MARLBOROUGH, MA 01752
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZBH | Grp Pres-Global Business | 0 | $96.39 | $0 | -$529.0K | 4 | 2026-09-15 |
| NEVRO CORP (NVRO) Delisted | President & CEO | 0 | $5.84 | $0 | $0 | 8 | 2025-04-03 |
| HOLOGIC INC (HOLX) Delisted | Group Pres, Global Diagnostics | 74,858 | $76.01 | $5.69M | -$3.40M | 15 | 2022-11-17 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-15 | ZBH | Sell (S) | −5,691 | -$529.0K | EDGAR |
| 2026-09-11 | ZBH | Notice (144) | −5,691 | -$529.0K | EDGAR |
| 2026-08-04 | ZBH | Mixed | +5,691 | -$395.4K | EDGAR |
| 2026-02-24 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2025-08-13 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | NEVRO CORP (NVRO) Delisted | Disp (D) | −852,337 | $0 | EDGAR |
| 2025-03-11 | NEVRO CORP (NVRO) Delisted | Tax (F) | −27,029 | -$156.0K | EDGAR |
| 2025-01-27 | NEVRO CORP (NVRO) Delisted | Tax (F) | −6,685 | -$34.5K | EDGAR |
| 2024-10-28 | NEVRO CORP (NVRO) Delisted | Tax (F) | −6,063 | -$29.4K | EDGAR |
| 2024-07-26 | NEVRO CORP (NVRO) Delisted | Tax (F) | −6,061 | -$59.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.